Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

World Diabetes Day

YICHANG, CHINA - NOVEMBER 14, 2025 - A patient with diabetes is injecting insulin in Yichang City, Hubei Province, China on November 14, 2025.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 14, 2025 - Insulin injected by a patient with diabetes in Yichang City, Hubei Province, China on November 14, 2025.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 14, 2025 - Insulin injected by a patient with diabetes in Yichang City, Hubei Province, China on November 14, 2025.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 14, 2025 - Insulin injected by a patient with diabetes in Yichang City, Hubei Province, China on November 14, 2025.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 14, 2025 - Insulin injected by a patient with diabetes in Yichang City, Hubei Province, China on November 14, 2025.

E

Sanofi Building A New Insulin Production Facility in Beijing

SHANGHAI, CHINA - NOVEMBER 6, 2023 - (FILE) Visitors visit the booth of Sanofi at the 6th CIIE in Shanghai, China, Nov 6, 2023.

E

Sanofi Building A New Insulin Production Facility in Beijing

SHANGHAI, CHINA - NOVEMBER 6, 2023 - (FILE) Visitors visit the booth of Sanofi at the 6th CIIE in Shanghai, China, Nov 6, 2023.

E

Sanofi Building A New Insulin Production Facility in Beijing

SHANGHAI, CHINA - NOVEMBER 6, 2023 - (FILE) Visitors visit the booth of Sanofi at the 6th CIIE in Shanghai, China, Nov 6, 2023.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 13, 2024 - Insulin, November 13, 2024, Yichang, Hubei, China. At present, China has more than 140 million patients with diabetes, ranking first in the world, and is expected to increase to 174 million by 2045.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 13, 2024 - Insulin, November 13, 2024, Yichang, Hubei, China. At present, China has more than 140 million patients with diabetes, ranking first in the world, and is expected to increase to 174 million by 2045.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 13, 2024 - Insulin, November 13, 2024, Yichang, Hubei, China. At present, China has more than 140 million patients with diabetes, ranking first in the world, and is expected to increase to 174 million by 2045.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 13, 2024 - A patient with diabetes was injected with insulin on November 13, 2024 in Yichang, Hubei Province, China. At present, China has more than 140 million patients with diabetes, ranking first in the world, and is expected to increase to 174 million by 2045.

E

World Diabetes Day

YICHANG, CHINA - NOVEMBER 13, 2024 - A patient with diabetes was injected with insulin on November 13, 2024 in Yichang, Hubei Province, China. At present, China has more than 140 million patients with diabetes, ranking first in the world, and is expected to increase to 174 million by 2045.

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

Box of Lantus insulin solutions produced by the Sanofi laboratory, for subcutaneous injection by pen to treat type 1 diabetes. The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

Box of Lantus insulin solutions produced by the Sanofi laboratory, for subcutaneous injection by pen to treat type 1 diabetes. The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

Box of Lantus insulin solutions produced by the Sanofi laboratory, for subcutaneous injection by pen to treat type 1 diabetes. The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

Box of Lantus insulin solutions produced by the Sanofi laboratory, for subcutaneous injection by pen to treat type 1 diabetes. The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

Box of Lantus insulin solutions produced by the Sanofi laboratory, for subcutaneous injection by pen to treat type 1 diabetes. The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young diabetic woman injects herself using a pen containing needles to monitor her blood sugar via an electronic device (ACCU CHEK system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young woman with diabetes monitors and treats her type 1 diabetes using an electronic device via a sensor glued to one of her arms (DEXCOM G6 system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young woman with diabetes monitors and treats her type 1 diabetes using an electronic device via a sensor glued to one of her arms (DEXCOM G6 system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young woman with diabetes monitors and treats her type 1 diabetes using an electronic device via a sensor glued to one of her arms (DEXCOM G6 system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young woman with diabetes monitors and treats her type 1 diabetes using an electronic device via a sensor glued to one of her arms (DEXCOM G6 system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young woman with diabetes monitors and treats her type 1 diabetes using an electronic device via a sensor glued to one of her arms (DEXCOM G6 system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young woman with diabetes monitors and treats her type 1 diabetes using an electronic device via a sensor glued to one of her arms (DEXCOM G6 system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Illustration Monitoring And Treatment Of Type 1 Diabetes

A young woman with diabetes monitors and treats her type 1 diabetes using an electronic device via a sensor glued to one of her arms (DEXCOM G6 system). The treatment of type 1 diabetes (called insulin-dependent diabetes) is based on subcutaneous injections of insulin, several times a day, to compensate for its lack of production by the body. June 3, 2023. Photo by Patrice Masante/ABACAPRESS.COM

E

Senate Committee Hearing - Washington

David Joyner, Executive Vice President and President of Pharmacy Services, CVS Health, appears before a Senate Committee on Health, Education, Labor, and Pensions hearing to examine the need to make insulin affordable for all Americans, in the Dirksen Senate Office Building in Washington, DC, Wednesday, May 10, 2023. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Senate Committee Hearing - Washington

United States Senator Bernie Sanders (Independent of Vermont), Chair, US Senate Committee Health, Education, Labor & Pensions (HELP) holds up a vile of insulin as he offers remarks during a Senate Committee on Health, Education, Labor, and Pensions hearing to examine the need to make insulin affordable for all Americans, in the Dirksen Senate Office Building in Washington, DC, Wednesday, May 10, 2023. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Senate Committee Hearing - Washington

United States Senator Bill Cassidy (Republican of Louisiana) listens while United States Senator Bernie Sanders (Independent of Vermont), Chair, US Senate Committee Health, Education, Labor & Pensions (HELP) offers remarks during a Senate Committee on Health, Education, Labor, and Pensions hearing to examine the need to make insulin affordable for all Americans, in the Dirksen Senate Office Building in Washington, DC, Wednesday, May 10, 2023. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Senate Committee Hearing - Washington

United States Senator Bernie Sanders (Independent of Vermont), Chair, US Senate Committee Health, Education, Labor & Pensions (HELP) offers remarks during a Senate Committee on Health, Education, Labor, and Pensions hearing to examine the need to make insulin affordable for all Americans, in the Dirksen Senate Office Building in Washington, DC, Wednesday, May 10, 2023. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Senate Committee Hearing - Washington

United States Senator Bill Cassidy (Republican of Louisiana), left, listens while United States Senator Bernie Sanders (Independent of Vermont), Chair, US Senate Committee Health, Education, Labor & Pensions (HELP) offers remarks during a Senate Committee on Health, Education, Labor, and Pensions hearing to examine the need to make insulin affordable for all Americans, in the Dirksen Senate Office Building in Washington, DC, Wednesday, May 10, 2023. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Senate Committee Hearing - Washington

David Ricks, Chair and Chief Executive Officer, Eli Lilly and Company, appears before a Senate Committee on Health, Education, Labor, and Pensions hearing to examine the need to make insulin affordable for all Americans, in the Dirksen Senate Office Building in Washington, DC, Wednesday, May 10, 2023. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Senate Committee Hearing - Washington

David Ricks, Chair and Chief Executive Officer, Eli Lilly and Company, appears before a Senate Committee on Health, Education, Labor, and Pensions hearing to examine the need to make insulin affordable for all Americans, in the Dirksen Senate Office Building in Washington, DC, Wednesday, May 10, 2023. Photo by Rod Lamkey/CNP/ABACAPRESS.COM

E

Senate Committee Hearing - Washington

United States Senator Bernie Sanders (Independent of Vermont), Chair, US Senate Committee Health, Education, Labor & Pensions (HELP) holds up a vile of insulin as he offers remarks during a Senate Committee on Health, Education, Labor, and Pensions hearing to examine the need to make insulin affordable for all Americans, in the Dirksen Senate Office Building in Washington, DC, Wednesday, May 10, 2023. Photo by Rod Lamkey/CNP/ABACAPRESS.COM